What is PreventionGenetics?
Founded in 2004 and headquartered in Marshfield, Wisconsin, PreventionGenetics operates as a CLIA and ISO 15189:2012 accredited clinical laboratory. The company specializes in providing comprehensive genetic diagnostic services globally, offering advanced solutions such as whole genome sequencing (PGnome®) and whole exome sequencing (PGxome®) at competitive price points. As a key player in the healthcare diagnostics industry, PreventionGenetics is committed to rigorous quality standards, making sophisticated genetic testing accessible for a wide array of medical applications, including hereditary disease screening, carrier testing, and the advancement of personalized medicine.
How much funding has PreventionGenetics raised?
PreventionGenetics has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in PreventionGenetics
PPP
Public-Private Partnership
What's next for PreventionGenetics?
The recent major strategic investment signals a pivotal phase for PreventionGenetics, likely enabling further development of its diagnostic platforms and expansion of its service offerings. This enterprise-level funding suggests a focus on scaling operations, enhancing research and development capabilities, and potentially broadening its market reach. The company's commitment to advanced genetic sequencing technologies positions it for significant growth within the evolving landscape of precision medicine and healthcare diagnostics.
See full PreventionGenetics company page
